Login
$KNSA
$72.98 -$3.75 (4.89%) Close

Company Executives

$KNSA Management Team

Mr. Sanjiv Patel

Chairman of the Board

Chief Executive Officer

Age 53
Compensation $6.113M USD
Sex Male

Mr. Mark Ragosa

Chief Financial Officer

Senior Vice President

Age 49
Compensation -
Sex Male

Mr. Eben Tessari

Chief Operating Officer

Senior Vice President

Age 41
Compensation $1.917M USD
Sex Male

Mr. Ross Moat

Senior Vice President and Chief Commercial Officer

Age 42
Compensation -
Sex Male

Mr. John Paolini

Senior Vice President and Chief Medical Officer

Age 58
Compensation $1.921M USD
Sex Male

Mr. Michael Megna

Chief Accounting Officer

Group Vice President - Finance

Age 52
Compensation -
Sex Male
Directors
10
serving now
Independent
0 of 1
stated in the proxy; 9 not stated
Average tenure
8.5 years
from year joined
CEO also chairs the board
Yes
Sanj K. Patel
Director Age On board Independent Committees Other public boards Pay Source
Stephen R. Biggar
55 2015
11 years
Not stated None stated TScan Therapeutics, Inc. Not stated
G. Bradley Cole
70 2020
6 years
Not stated None stated Castle Biosciences Not stated
Barry D. Quart
69 2015
11 years
Not stated None stated None stated Not stated
Sanj K. Patel
56 2015
11 years
Not independent None stated None stated Paid as CEO
Thomas R. Malley
57 2016
10 years
Not stated None stated Kura Oncology, Inc. Not stated
Richard S. Levy, M.D.
68 2019
7 years
Not stated None stated Madrigal Pharmaceuticals, Inc. Not stated
Felix J. Baker, Ph.D.
57 2015
11 years
Not stated None stated Kodiak Sciences, Inc. Not stated
M. Cantey Boyd
46 2024
2 years
Not stated None stated None stated Not stated
Tracey L. McCain
58 2018
8 years
Not stated None stated None stated Not stated
Kimberly J. Popovits
67 2018
8 years
Not stated None stated Exact Sciences, 10x Genomics, Inc., Genomic Life, Kardigan, Rhythm Pharmaceuticals Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

1 disclosed in the proxy filed Apr 16, 2026
certain executive officers, holders of 5% or more of a class of our voting shares and entities affiliated with certain of our directors
certain executive officers, holders of 5% or more of a class of our voting shares, and entities affiliated with certain of our directors
Amount not stated

Investors' rights agreement granting specified registration rights with respect to Class A Shares held by these shareholders

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support